(58 days)
No
The 510(k) summary describes a standard medical catheter and does not mention any AI or ML components or functionalities.
No
The device is a catheter designed for delivering intravenous therapies and blood sampling, which are supportive functions, not direct therapeutic interventions that treat a disease or medical condition.
No
The device is a peripherally placed catheter for vascular access and fluid administration, including power injection of contrast, and blood sampling. It does not perform a diagnostic function but rather provides the means for certain procedures that may be part of a diagnostic process (e.g., blood sampling, contrast injection).
No
The device description clearly indicates it is a physical catheter made from polyurethane materials, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes the device as providing "short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast". This is a description of a device used in vivo (within the body) for direct patient care, not for testing samples in vitro (outside the body).
- Device Description: The description details a catheter designed for insertion into the peripheral venous system. This is consistent with an in vivo medical device.
- Lack of IVD Characteristics: There is no mention of the device being used to analyze biological samples, detect analytes, or provide diagnostic information based on in vitro testing.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device's function is to provide access to the vascular system for therapeutic and sampling purposes, which is not the definition of an IVD.
N/A
Intended Use / Indications for Use
The PowerMidline™ Catheters are indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of the procedure. The PowerMidline™ Catheters are suitable for use with power injectors.
Product codes (comma separated list FDA assigned to the subject device)
PND
Device Description
The dual lumen PowerMidline™ catheters are a family of peripherally placed catheters made from radiopaque body-softening polyurethane materials. Each dual lumen PowerMidline™ catheter is designed with kink-resistant, reverse taper design. The dual lumen PowerMidline™ catheters are offered in a 4 F dual lumen (DL) and 5 F dual lumen (DL) configuration for reliable short term (less than 30 days) vascular access. These catheters are offered in 20 cm trimmable lengths. The dual lumen PowerMidline™ catheters are suitable for use with power injectors.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peripheral venous system
Indicated Patient Age Range
any patient population
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
As part of Bard Access Systems, Inc.'s design controls, a risk analysis was conducted to assess the impact of the proposed device modifications. Based upon the results of the risk analysis, the necessary design control activities were identified to ensure that specified design requirements were met. The performance tests completed on the subject device were limited to those tests required to support a determination of substantial equivalence to the predicate device. In addition, when technological characteristics between the subject and predicate device were found to be identical, results of the performance testing conducted on the predicate device were applied to the subject device. As required by the risk analysis, the following table identifies the performance tests completed on the subject device based upon the specific modifications made to develop the subject device. The table includes a description of testing completed and the standard(s) utilized with each test.
| Testing Completed | ISO Standard / FDA Guidance / BAS Protocols Utilized |
|---|---|
| Test and Report Priming Volume | Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, March 16, 1995; BAS Internal Protocols/Procedures |
| Shaft Tensile | ISO 10555-1: 2013, Sterile, single-use intravascular catheters, Part 1: General requirements |
| Test and Report Modulus and Elongation Requirements | Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters, March 16, 1995 |
| Assembly Burst (Burst Pressure with Power Injection) | Not Specified |
| Catheter Assembly Leak | Not Specified |
| Catheter Assembly Tensile | ISO 10555-1: 2013, Sterile, single-use intravascular catheters, Part 1: General requirements |
| Test and Report Gravity Flow | Not Specified |
| Device Dimensional Characterization | Not Specified |
| Catheter Cyclic Kink | Not Specified |
| Tip Displacement During Power Injection | BAS Internal Protocols/Procedures |
| Power Injection Testing | ISO 10555-1: 2013, Sterile, single-use intravascular catheters, Part 1: General requirements; BAS Internal Protocols/Procedures |
| Biocompatibility Evaluation | Per ISO 10993-1:2009, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing Within a Risk Management Process, a biocompatibility evaluation was performed based upon the modifications made to develop the subject device. |
| Risk Management | Risk management, including a failure modes and effects analysis (FMEA), of the subject device was conducted in accordance with BS EN ISO 14971:2012, Medical Devices – Application of Risk Management to Medical Devices. |
Key results: Per design control requirements as specified in 21 CFR 820.30, the subject device met all predetermined acceptance criteria derived from the above listed tests and demonstrated substantial equivalence as compared to the cited predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5200 Intravascular catheter.
(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 14, 2016
C.R. Bard, Inc. % Casey Coombs Regulatory Affairs Specialist 605 North 5600 West Salt Lake City, Utah 84116
Re: K162900
Trade/Device Name: PowerMidline Catheter Regulation Number: 21 CFR 880.5200 Regulation Name: Intravascular Catheter Regulatory Class: II Product Code: PND Dated: November 17, 2016 Received: November 18, 2016
Dear Mr. Coombs:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Image /page/1/Picture/8 description: The image contains a signature that appears to be of a person named Tina Kiang. The signature is stylized and includes a flourish to the left of the name. Below the name, there is a dash followed by the letter 's'. The background of the image has a watermark of the letters FDA.
Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K162900
Device Name PowerMidline Catheter
Indications for Use (Describe)
The PowerMidline™ Catheters are indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of the procedure. The PowerMidline™ Catheters are suitable for use with power injectors.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for BARD ACCESS SYSTEMS. The word "BARD" is in large, bold, sans-serif font, with each letter outlined in black. Below the word "BARD" is the phrase "ACCESS SYSTEMS" in a smaller, sans-serif font.
510(k) Summary
21 CFR 807.92(a)
| General
| Provisions | Submitter Name: | Bard Access Systems, Inc. |
|---|---|---|
| Submitter Address: | 605 North 5600 West | |
| Salt Lake City, UT 84116 | ||
| Contact Person: | Mr. Casey Coombs | |
| Regulatory Affairs Specialist | ||
| Telephone Number: | (801) 522-5869 | |
| Fax Number: | (801) 522-4969 | |
| Date of Preparation: | November 27, 2016 | |
| Subject | ||
| Device | Trade Name: | PowerMidline™ Catheter |
| Common Name: | Intravascular Catheter | |
| Regulation Name: | Intravascular Catheter | |
| Product Code: | PND | |
| Regulation: | 21 CFR § 880.5200 | |
| Regulatory Class: | Class II | |
| Classification Panel: | General Hospital | |
| Predicate | ||
| Device | Predicate Trade Name: | PowerMidline™ Catheter |
| Common Name: | Intravascular Catheter | |
| Regulation Name: | Intravascular Catheter | |
| Premarket Notification: | K153393 (cleared June 28, 2016) | |
| Manufacturer: | Bard Access Systems, Inc. | |
| Product Code: | PND | |
| Regulation: | 21 CFR § 880.5200 | |
| Regulatory Class: | Class II | |
| Classification Panel: | General Hospital | |
| Reference | ||
| Device | Reference Trade Name: | PowerPICCT™ SV Catheter |
| Common Name: | Peripherally Inserted Central Catheter (PICC) | |
| Regulation Name: | Percutaneous, implanted, long-term intravascular | |
| catheter | ||
| Premarket Notification: | K102159 (cleared November 17, 2010) | |
| Manufacturer: | Bard Access Systems, Inc. | |
| Product Code: | LJS | |
| Regulation: | 21 CFR § 880.5970 | |
| Regulatory Class: | Class II | |
| Classification Panel: | General Hospital |
4
| Reference
Device | Reference Trade Name: 6 F Triple Lumen PowerPICCT™ Catheter
Common Name: Peripherally Inserted Central Catheter (PICC)
Regulation Name: Percutaneous, implanted, long-term intravascular
catheter
Premarket Notification: K053501 (cleared January 13, 2006)
Manufacturer: Bard Access Systems, Inc.
Product Code: LJS
Regulation: 21 CFR § 880.5970
Regulatory Class: Class II
Classification Panel: General Hospital |
|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device
Description | The dual lumen PowerMidline™ catheters are a family of peripherally placed
catheters made from radiopaque body-softening polyurethane materials. Each
dual lumen PowerMidline™ catheter is designed with kink-resistant, reverse
taper design. The dual lumen PowerMidline™ catheters are offered in a 4 F
dual lumen (DL) and 5 F dual lumen (DL) configuration for reliable short term
(less than 30 days) vascular access. These catheters are offered in 20 cm
trimmable lengths. The dual lumen PowerMidline™ catheters are suitable for
use with power injectors. |
| Intended Use | The PowerMidline™ Catheter is intended for short term peripheral access for
selected intravenous therapies, blood sampling, and power injection of
contrast media. |
| Indications For
Use | The PowerMidline™ Catheters are indicated for short term access to the
peripheral venous system for selected intravenous therapies, blood sampling,
and power injection of contrast media. These catheters may be used for any
patient population with consideration given to adequacy of vascular anatomy
and appropriateness of the procedure. The PowerMidline™ Catheters are
suitable for use with power injectors. |
| Technological
Characteristics | The technological characteristics of the subject PowerMidline™ Catheters are
substantially equivalent with respect to basic design, materials and function to
those of the cited predicate device.
Key modifications made to the subject device when compared to the predicate
device are as follows:
Modifications made to the number of lumens and extension legs to
introduce the dual lumen configurations Dimensional modifications made to introduce a 5 French size dual
lumen catheter Modifications made to the catheter junctions to accommodate the dual
lumen configurations Material modifications to the extension leg, luer hub, and catheter
junction components to introduce the dual lumen configurations Labeling modifications to reflect the dual lumen configurations The following table provides a comparison between the subject and predicate
device. |
5
| Subject and Predicate Device Comparison Table | |||
|---|---|---|---|
| Attribute | Subject Device: | ||
| Dual Lumen | |||
| PowerMidline™ Catheter | Predicate Device: | ||
| Single Lumen | |||
| PowerMidline™ Catheter | |||
| (K153393) | |||
| Technological | |||
| Characteristics | Owner | Same as predicate | Bard Access Systems, Inc. |
| Classification | Same as predicate | PND - 21 CFR 880.5200 - | |
| Short-term - Intravascular | |||
| Catheter | |||
| 510(k) Status | Subject of this Premarket | ||
| Notification | K153393 - Clearance date | ||
| June 28, 2016 | |||
| Indications | |||
| for Use | Same as predicate | The PowerMidline™ | |
| Catheters are indicated for | |||
| short term access to the | |||
| peripheral venous system for | |||
| selected intravenous | |||
| therapies, blood sampling, | |||
| and power injection of | |||
| contrast media. These | |||
| catheters may be used for | |||
| any patient population with | |||
| consideration given to | |||
| adequacy of vascular | |||
| anatomy and | |||
| appropriateness of the | |||
| procedure. The | |||
| PowerMidline™ Catheters | |||
| are suitable for use with | |||
| power injectors. | |||
| Duration of | |||
| Use | Same as predicate | Short term ( |